<DOC>
	<DOCNO>NCT01719107</DOCNO>
	<brief_summary>The aim study investigate effect L. reuteri DSM 17938 pain frequency severity child 5-16 year old diagnosis FAP .</brief_summary>
	<brief_title>Efficacy Dietary Supplementation With Lactobacilllus Reuteri DSM 17938 Functional Abdominal Pain ( FAP ) Children</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled study . Subjects 5-16 year age FAP define Rome III criterion pain severity least 40 mm 100 mm VAS scale pain frequency least 1 episode per week precede 8 week recruit . In accordance specific Rome III criterion inclusion , FAP define variable combination chronic recurrent gastrointestinal symptom explain structural biochemical abnormality . A study questionnaire record pain gastrointestinal symptom use . One-hundred six ( 106 ) Subjects randomize receive either dietary supplementation L. reuteri DSM 17938 ( 2 chewable tablet breakfast ) , number comparable placebo tablet , 4 week . Supplementation stop 4 week , subject follow additional 4 week . The subject complete diary record frequency intensity pain , use medication , deviation usual diet , physical activity , absence school activity . Gastrointestinal symptom assess GSRS ( Gastrointestinal Symptom Rating Score ) . Subjects/caregivers instruct maintain usual diet throughout study , consume probiotic ( food supplement ) entire study period . The symptom diary complete daily parent report information frequency pain episode , location pain , presence absence associate symptom , need take medication pain interference normal activity . The intensity symptom assess use Wong-Baker Faces scale .</detailed_description>
	<mesh_term>Abdominal Pain</mesh_term>
	<criteria>Subjects recruit accord follow inclusion criterion : FAP ( Functional Abdominal Pain ) accord Rome III criterion Child/Adolescent ; 1 abdominal pain episode per week past 8 week Informed consent study participant least one parent/legal guardian ; Age 516 year ; Pain severity study entry must least 40 mm 100 mm VAS scale ; Pain frequency least 1 episode per week precede 8 week ; Ability understand comply requirement trial ; Stated availability throughout study period Subjects present one follow criterion exclude participation study : Chronic illness ; Surgery gastrointestinal tract Any symptoms/signs organic disease and/or abnormal result laboratory assay ( total blood count , serum glucose , urea , electrolyte , amylase , SGOT , SGPT , anti tTG antibody , breath H2 test , suggest disease FAP ; Weight loss 5 % body weight precede 3 month ; Exposure drug FAP past 2 week . Exposure probiotic antibiotic within 4 week prior study ; subject include follow washout period 4 week . Participation interventional clinical trial past 3 month ; Subjects special dietary need</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Functional abdominal pain</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Lactobacilus reuteri</keyword>
</DOC>